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The healing powers of essential oils, the sec-
ondary metabolism products of oil plants, have been
known for centuries. Despite the long history of
their use, chemical composition of essential oils was
not analyzed until the nineteenth century, when the
development of chromatographic techniques
allowed researchers to study the plant products in far
greater detail, but only chromatography combined
with mass spectrometry could be used in more
advanced analysis of the compounds (1). In chemi-
cal terms, oils are mixtures of carbohydrates, alco-
hols, aldehydes, ketones as well as esters and ether
derivatives of both terpenes (mainly mono- and
sesquiterpenes) and propylbenzene. The specific
chemical composition of an essential oil depends on
the plant species but the relative percentages of the
different components will vary according to the cli-
mate, growing conditions, stage of vegetation as
well as the part of the plant used (roots, rhizomes,
herbs, leaves, flowers, fruits, seeds or bark). The
rich composition of essential oils determines their
extremely wide range of biological activity, includ-
ing activity against bacteria, viruses and fungi which
depends mainly on the nature of the leading chemi-
cal component. Essential oils containing phenols
(thymol and carvacrol), eugenol and cinnamalde-
hyde exhibit the strongest antibacterial activity. Oils
have lipophilic properties, which allow them to rap-
idly penetrate the cell wall and cytoplasmic mem-
brane causing damage to the cell. Essential oils
interfere with the transport proteins, which leads to
leakage of bacterial cell components, inhibits the
hydrogen pump and ATP formation, and affects the
cytoplasmic enzymes, which ultimately causes cell
lysis (2-4). The above-mentioned activity of essen-
tial oils and their major constituents shows signifi-
cant therapeutic potential in the treatment of infec-
tions. Antioxidant, immunostimulatory and anti-
inflammatory properties of the oils are of equal
importance (5).
ACTIVITY OF THYME OIL (OLEUM THYMI) AGAINST 
MULTIDRUG-RESISTANT ACINETOBACTER BAUMANNII 
AND PSEUDOMONAS AERUGINOSA
DANUTA TROJANOWSKA, PAULINA PALUCHOWSKA*, £UKASZ SOJA and ALICJA BUDAK
Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Jagiellonian University Medical
College, 9 Medyczna St., 30-688 KrakÛw, Poland
Abstract: Almost as soon as antibiotics were introduced to treat infectious diseases, it could be observed that
bacteria were able to develop resistance against them. Currently, multidrug-resistant strains are being isolated
mainly in the hospital environment. These are primarily non-fermenting Gram-negative bacilli, which exhibit
both natural and acquired resistance to multiple antibiotics and disinfectants rendering them difficult to eradi-
cate. The development of new, effective and safe substances that prevent troublesome infections is greatly need-
ed to provide alternative therapeutic options for patients. There is increasing interest in drugs of natural origin,
including essential oils. It is of particular interest that, although active against many bacterial strains, they do
not contribute to antibacterial resistance against their components. The aim of our study was to evaluate the in
vitro antibacterial activity of thyme oil against multidrug-resistant strains of A. baumannii and P. aeruginosa
using the disc diffusion and macrodilution methods. The strains were isolated from patients hospitalized in the
years 2013-2014. The in vitro antibacterial activity of thyme oil was assessed by the disc diffusion method and
the inhibition zones for the oil at different concentrations, produced against A. baumannii, ranged from 7 to 44
mm. Low level of activity of thyme oil was observed against P. aeruginosa strains. The results of serial dilu-
tion tests confirmed the high activity of thyme oil against A. baumannii isolates, expressed as MIC values rang-
ing from 0.25 to 2 µL/mL. These results suggest the need for further studies of antibacterial activity of essen-
tial oils, especially against multidrug-resistant bacterial isolates.
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An outstanding achievement of the 20th century
was the discovery of antibiotics which revolution-
ized the treatment of infectious diseases but unfortu-
nately, shortly after their introduction to clinical
practice, the emergence of bacterial resistance to
antimicrobial agents began. Recently, a progressive
increase in drug resistance among pathogenic
microorganisms has been confirmed, which
adversely affects the outcomes of infected patients.
Among the bacterial strains, the following
groups of multidrug-resistant microorganisms can
be currently distinguished: MDR (multidrug-resist-
ant), XDR (extensively drug-resistant) and PDR
(pandrug-resistant), referred to as alert pathogens.
Multidrug-resistant microorganisms are most com-
monly found in the hospital environment, where
they can cause serious nosocomial infections, occur-
ring particularly in the following hospital units:
intensive care, burn therapy, surgical, hematological
and oncological (6). These are primarily non-fer-
menting Gram-negative bacilli belonging to the
species Acinetobacter (A.) baumannii or
Pseudomonas (P.) aeruginosa. Microorganisms,
which can survive in nutrient-poor conditions, colo-
nize the hospital environment including sanitation
facilities, ventilation and the medical equipment,
mainly respirators, inhalators and venous or urinary
catheters (7, 8). They are responsible for surgical
site infections and infections of burns in patients
hospitalized in surgical wards and burn units,
whereas in the intensive care units (ICU) they are
the most important species that cause infections of
the respiratory system and urinary tract. Their abili-
ty to form biofilm contributes to their survival and
colonization of respirators and urinary catheters (9,
10). Resistance to many antibiotics and disinfec-
tants, primarily acquired but also natural, exhibited
by many harmful pathogens makes them difficult to
eradicate, therefore the search for new, effective and
safe substances, that would prevent troublesome
infections, is becoming increasingly more urgent. It
should be noted that recently drugs of natural origin,
including essential oils, have been the subject of
growing interest. Essential oils, although active
against many bacterial strains, do not contribute to
antibacterial resistance against their components. It
cannot be ruled out that using essential oils in the
treatment of infections caused by multidrug-resist-
ant microorganisms could be a powerful alternative
to synthetic antibiotics whose effectiveness has
declined over the last decade. In the search for com-
pounds or substances that prevent infections or the
spread of infectious agents in hospital environment,
we studied the effect of thyme oil on some selected
multidrug-resistant clinical strains of non-ferment-
ing bacilli.
The aim of the study was to evaluate the in
vitro antibacterial activity of thyme oil (Oleum
Thymi) against the selected multidrug-resistant
strains of A. baumannii and P. aeruginosa, using the
disc diffusion and macrodilution methods.
EXPERIMENTAL
Material
We studied the natural thyme oil (Bakalland,
Warszawa, Poland) certified according to the
National Institute of Hygiene standards (PZH cer-
tificate No. HØ/15994/96).
The original, 100% oil was serially diluted in
dimethyl sulfoxide (DMSO; Merck, Warszawa,
Poland) to achieve the final concentrations of 50, 25,
12.5, 6.25 and 3.125%. We examined the following
strains of A. baumannii: 59 clinical isolates and the
reference strain ATCC 19606 and P. aeruginosa
strains: 29 clinical isolates and the reference strain
ATCC 27853. The strains were collected from sub-
jects hospitalized between 2013 and 2014 at the L.
Rydygier Memorial Specialized Hospital in
KrakÛw, in the following wards: anesthesia and
intensive care, burn therapy, multiple trauma care,
orthopedics and neuro-orthopedics, neurology and
brain injuries, plastic surgery, nephrology, cardiolo-
gy and internal medicine as well as toxicology.
Acinetobacter baumannii isolates were cul-
tured from endotracheal aspirates (22 strains), blood
samples (17), wound swabs (12), urine (4), and
catheters (4), whereas P. aeruginosa isolates were
cultured from the wound swabs (11), endotracheal
aspirates (9), urine (4), swabs of ear (4) or conjunc-
tival sac (1).
All the examined A. baumannii and P. aerugi-
nosa strains were multidrug-resistant. Susceptibility
testing of A. baumannii isolates (59) was performed
against imipenem (IPM), meropenem (MEM),
amikacin (AMK), gentamicin (GEN), tobramycin
(TOB), ciprofloxacin (CIP), colistin (CST), and
trimethoprim/sulfamethoxazole (SXT). The follow-
ing antibiotics were used to determine the suscepti-
bility of P. aeruginosa strains (29): piperacillin
(PIP), piperacillin/tazobactam (TZP), ceftazidime
(CAZ), cefepime (FEP), imipenem, meropenem,
aztreonam (ATM), amikacin, gentamicin,
tobramycin, ciprofloxacin, and colistin.
Methods
The antimicrobial susceptibility of A. bauman-
nii and P. aeruginosa strains was evaluated by disc
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diffusion technique (Oxoid Ltd., Hampshire, United
Kingdom) and, to selected antimicrobials, with the
use of the automated system Vitek 2 Compact
(bioMÈrieux, Marcy lí…toile, France) and the mini-
mum inhibitory concentrations (MICs) were deter-
mined. The obtained results suggest that these iso-
lates should be classified as multidrug-resistant
(Figs. 1 and 2).
Antibacterial activity of thyme oil was deter-
mined by disc diffusion and tube macrodilution
methods in order to find the minimum inhibitory
concentration capable of inhibiting the growth of
bacteria.
The isolates were inoculated onto solid medi-
um, Trypticasein Soy Agar (bioMÈrieux, Marcy lí…-
toile, France) and incubated at 35OC for 20 h. Next,
the colonies were suspended in 0.85% saline solu-
tion in order to obtain an equivalent of 0.5
McFarland units.
The disc diffusion tests were performed on
Mueller-Hinton agar (bioMÈrieux, Marcy lí…toile,
France) in 90 mm-diameter Petri dishes. Bacterial
suspensions were inoculated onto the culture plates
and then 6 mm sterile filter paper discs, containing
decreasing concentrations of thyme oil (15 µL),
were placed on the surface of the plates. After 20 h
of incubation at 35OC, the diameters of the growth
inhibition zones were measured in mm.
Minimum inhibitory concentrations were
determined by a broth macrodilution method in
Trypticasein Soy Broth (BioCorp, Warszawa,
Poland). The original thyme oil was diluted in
Figure 1. Susceptibility of Acinetobacter baumannii strains to selected antimicrobial agents
Figure 2. Susceptibility of Pseudomonas aeruginosa clinical strains to selected antimicrobial agents.
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dimethyl sulfoxide (DMSO). The volumes were
matched in a way that the solvent volume was the
smallest possible. First, a stock solution was pre-
pared by dissolving the original thyme oil in DMSO
to the concentration of 16 µL/mL, and then serial
dilutions ranging from 8 µL/mL do 0.125 µL/mL
were made in test-tubes containing 1 mL of broth.
Next, 100 µL of bacterial suspension, equivalent to
0.5 McFarland units, was added to each tube and
incubated at 35OC for 20 h. After this time, the min-
imum inhibitory concentration (MIC µL/mL) was
determined as the lowest thyme oil concentration at
which no bacterial growth could be observed.
Controls of the broth, thyme oil and bacterial growth
were run in parallel with all tests.
RESULTS
In the present study we investigated in vitro the
antimicrobial activity of thyme oil against bacterial
reference strains. Disc diffusion tests were per-
formed and the diameters of zones of inhibition
Figure 3. Growth inhibition zones against an Acinetobacter baumannii clinical strain, thyme oil at the concentration of: A. 100%; B. 50%;
C. (25%, 12.5%, 6.25%). Comparison of the susceptibility to thyme oil with the resistance to the selected antibacterial agents: IPM, GEN,
TOB, CIP, SXT (D).
Table 1. Range of zone diameters of inhibition of Acinetobacter
baumannii (clinical and reference strains) growth in relation to the
tested thyme oil concentrations determined using the disc diffu-
sion technique.
Tiyme oil Range of inhibition
concentration [%] zones [mm]
100 26 ñ 44
50 19 ñ 30
25 11 ñ 22
12.5 8 ñ 17
6.25 7 ñ 11 
Table 2. Range of zone diameters of inhibition of clinical
Pseudomonas aeruginosa strains growth in relation to the tested
thyme oil concentrations determined using the disc diffusion tech-
nique.
Tiyme oil Range of inhibition
concentration [%] zones [mm]
100 0 ñ 12  
50 0 ñ 7  
25 0 
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around the discs impregnated with thyme oil were
measured. The zone diameters for the reference
strain ATCC 19606 of A. baumannii ranged from 9
to 38 mm at the oil concentrations of 100, 50, 25,
12.5 and 6.25%, whereas at the oil concentrations of
100, 50 and 25%, the reference strain ATCC 27853
of P. aeruginosa produced inhibition zones ranging
from 7 to 18 mm. The same concentrations were
used to evaluate the antibacterial activity of thyme
oil against pathogens isolated from inpatients. Our
results confirmed that the antibacterial activity of
thyme oil against the studied strains of A. bauman-
nii was high. The size of the inhibition zones ranged
from 26 to 44 mm for thyme oil at the concentration
of 100%, from 19 to 30 mm for 50%, from 11 to 22
mm for 25% and from 8 to 17 mm for 12.5%. The
smallest inhibition zones, ranging from 7 to 11 mm,
were produced at the oil concentration of 6.25%
(Table 1). The results of bacterial susceptibility test-
ing of thyme oil against a selected clinical isolate of
A. baumannii are shown in Figure 3.
Our study revealed very low level of activity of
thyme oil against the tested clinical strains of P.
aeruginosa. Thyme oil produced bacterial growth
inhibition zones ranging from 7 to 12 mm for 11 P.
aeruginosa strains, but it proved to be totally inactive
against eighteen isolates of this pathogen (Table 2).
The next step of the study was to determine
MIC values of thyme oil at different concentrations
against A. baumannii strains using the serial dilution
method. The obtained results confirmed that the
antibacterial activity of thyme oil, expressed as MIC
values, ranging from 0.25 to 2 µL/mL, was high.
The MIC50 and MIC90 of these isolates were found to
be 0.5 and 1 µL/mL, respectively. The lowest MIC
of 0.25 µL/mL was observed against ten A. bauman-
nii strains while the values of 0.5 µL/mL and 1
µL/mL were found against 31 and 17 isolates,
respectively. Only one strain exhibited MIC of 2
µL/mL (Fig. 4).
DISCUSSION AND CONCLUSION
In the twenties of the last century, a French
chemist RenÈ GattefossÈ became interested in the
healing properties of essential oils when he applied
lavender oil to a burn on his hand. In 1937,
GattefossÈ coined the word ìaromatherapyî to
describe the use of essential oils in therapy (2).
Recently, there has been a growing interest in the
use of natural products in medicine. Despite bring-
ing new antimicrobial drugs, mainly antibacterial, to
market they are still inefficient. There is an urgent
need to search for new agents, including the natural
products showing high antimicrobial activity and no
adverse effects. Research has proven that essential
oils have a remarkable antimicrobial potential and
are highly effective against both Gram-positive and
Gram-negative bacteria. Several studies have docu-
mented that essential oils can increase the bacterial
susceptibility to drugs, even of the most resistant
strains (3, 4, 11), therefore therapeutic strategies of
essential oils in combination with antibiotics not
only could improve treatment outcomes but could
also slow down the increase in antibiotic-resistant
bacteria. The strongest antibacterial activity is
exhibited by phenolic-rich essential oils; one of
them is thyme oil which is derived from thyme herb
Figure 4. Thyme oil MIC values (µL/mL) determined against clinical strains of Acinetobacter baumannii
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(Thymus vulgaris) (12). Thymol, the main compo-
nent, accounts for 30-50% of thyme oil and car-
vacrol up to 5%. Thyme essential oil also contains a
range of additional compounds, such as terpenes,
tannins, flavonoids, saponins and minerals (2).
Thyme acts as an expectorant so it is used in respi-
ratory tract diseases. Due to its antimicrobial and
antiseptic activity, thyme is used in skin disinfec-
tion, treatment of seborrheic dermatitis and bacteri-
al eczema as well as to accelerate wound healing.
Thyme has also many uses in aromatherapy and skin
care: massage, baths, inhalation and facial cleansing
(2, 13, 14).
The results of our studies confirmed the high
activity of thyme oil against multidrug-resistant
clinical strains of A. baumannii isolated from
patients hospitalized in various wards. We obtained
similar results using the disc diffusion technique
(zones of bacterial growth inhibition ranged from 7
to 44 mm) and the serial dilution method (MICs
from 0.25 to 2 µL/mL). Our results are consistent
with that of £ysakowska et al., who studied mul-
tidrug-resistant bacilli of the genus Acinetobacter
isolated from the hospital environment and hospital-
ized patients. They determined the MIC values in
the range from 0.25 to 1 µL/mL (15).
Hersch-MartÌnez et al. studied susceptibility of
various species of bacteria to thyme oil using disc
diffusion method and they obtained an average
diameter of the zones of inhibited bacterial growth
ranging from 6.4 to 35.7 mm. For P. aeruginosa
strains, this value was 6.4 mm (16). In our study, P.
aeruginosa zone of inhibition did not exceed the
diameter of 12 mm, which was regarded as very low
antibacterial effect.
Hammer et al. determined the antimicrobial
activity of 53 essential oils, including oil of thyme,
against various bacterial species with the use of seri-
al dilution technique, both agar and broth. The min-
imum inhibitory concentrations with thyme oil to
the reference strain NTCT 7844 of A. baumannii
was 0.12 µL/mL and P. aeruginosa NTCT 10662 -
over 2 µL/mL (17).
KÍdzia et al. examined the antimicrobial activ-
ity of thyme oil against 31 bacterial strains of vari-
ous species, including three A. baumannii strains
and one strain from each of the species: P. aerugi-
nosa and P. stutzerii. They used serial dilutions of
thyme oil in Mueller-Hinton agar. The MIC values
for A. baumannii strains were found to range from
0.5 to 2 mg/mL, for P. aeruginosa over 4 mg/mL and
for P. stutzerii 0.5 mg/mL (18).
Sienkiewicz and Wasiela tested 30 P. aerugi-
nosa strains using thyme oil prediluted in ethanol
and then serially diluted in agar. The MIC values
were found to range from 1 to 2.5 µL/mL (19).
In agreement with these findings, we also
demonstrated high antimicrobial activity of thyme
oil against A. baumannii strains.
Although these findings are encouraging, it is
necessary to continue research on antibacterial
activity of essential oils, especially with regard to
multidrug-resistant strains of clinically important
bacterial species. It is worth mentioning that many
products containing essential oils and recommended
in treatment of various conditions, are protected by
patents. Synergistic antimicrobial effect of essential
oils and antibacterial agents not only could help to
eradicate the etiological agent of infection but could
also slow down the increase in antibiotic-resistant
bacteria (20). Current treatments of serious bacterial
infections caused by resistant strains include com-
bined therapies of broad-spectrum antibiotics (21).
Particular attention should be given to colistin,
a polymyxin antibiotic, which has been reintroduced
in clinical practice for treatment of infections due to
multidrug-resistant bacterial strains including A.
baumannii and P. aeruginosa (MDR, XDR, PDR).
Colistin, even though effective, exhibits adverse
effects and may interact with other medicines. This
is particularly of concern in patients with serious
comorbidities. Unfortunately, among the colistin-
only-susceptible hospital isolates, colistin-resistant
strains have emerged recently (22). Prolonged
antimicrobial therapy in hospitalized patients per-
turbs the normal flora, promoting worsening of the
serious opportunistic infections.
In the recent years, multidrug-resistant strains
have been increasingly isolated but also a small
number of new antimicrobial drugs have been intro-
duced for clinical use. Therefore, it is necessary to
continue research on new products, including essen-
tial oils, because their use in combination therapy
with antibiotics could be an alternative therapy for
selected infections.
It is necessary to continue research on antibac-
terial activity of essential oils as bacterial drug-
resistance to currently administered treatments is
ever increasing. Our results show that the in vitro
activity of thyme oil against multidrug-resistant
strains of A. baumannii is high and this suggests that
this oil can be used in the treatment of infectious dis-
eases and to eradicate alert pathogens from the hos-
pital environment.
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